Good Laboratory Practice Preclinical Safety Studies for GSK2696273 (MLV Vector-Based Ex Vivo Gene Therapy for Adenosine Deaminase Deficiency Severe Combined Immunodeficiency) in NSG Mice.

Overview
Research
Identity
Additional Document Info
View All

authors

Carriglio, Nicola
Cristofori, Patrizia
Richards, Jane
Staton, Hazel
Appleby, Jonathan
Aiuti, Alessandro
Sauer, Aisha V
Klapwijk, Jan
Hernandez, Raisa Jofra
Vezzoli, Michela
Chanut, Franck
Lowe, Rhiannon
Draghici, Elena
Nord, Melanie
Albertini, Paola

publication date

January 2017

published in

Human gene therapy. Clinical development Journal

has subject area